Pain Management Medications for Postoperative Pain
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to find the best way to manage pain after nose surgery by comparing two different painkiller combinations. One group will take a mix of Acetaminophen and Hydrocodone (known as Norco), while the other will use Acetaminophen and Ibuprofen. Researchers will track how well each combination controls pain, the number of pills participants take, and any side effects. Candidates may qualify if they have undergone nose surgery for cosmetic reasons or to fix breathing problems and can speak English. As a Phase 2 trial, this research focuses on measuring the treatment's effectiveness in an initial, smaller group of people.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. It's best to discuss this with the trial organizers or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the combination of hydrocodone and acetaminophen, as found in Norco, is often used to manage moderate to severe pain and proves effective after surgery. However, it can cause serious side effects and overdose, particularly in those unaccustomed to strong painkillers. These side effects include nausea, dizziness, or more severe reactions.
In contrast, studies have found that combining acetaminophen and ibuprofen also effectively reduces post-surgical pain. This combination is generally gentler on the body, with fewer risks compared to opioids. Common side effects might include an upset stomach or mild allergic reactions.
Both treatments are used for pain management but present different safety concerns. The choice often depends on balancing pain relief needs with potential side effects.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these treatments for postoperative pain because they explore the combined use of Tylenol and Ibuprofen, offering a potential alternative to opioids like Norco. Unlike typical opioid treatments, which can carry risks of addiction and side effects, the combination of Tylenol and Ibuprofen targets pain through different pathways without involving opioids. This approach could provide effective pain relief while minimizing the risk of dependency, making it a safer option for managing postoperative pain.
What evidence suggests that this trial's treatments could be effective for postoperative pain?
Research has shown that Norco, a combination of hydrocodone and acetaminophen, effectively manages moderate-to-severe pain after surgery. It is often used when other pain medicines are insufficient. In this trial, participants in Drug Arm A will receive Norco. Conversely, participants in Drug Arm B will receive a combination of Tylenol (acetaminophen) and ibuprofen, which has also demonstrated strong pain relief. Studies suggest that this combination can sometimes match or surpass the effectiveness of opioids. Both treatments have evidence supporting their pain management capabilities, with effectiveness varying by situation.12356
Who Is on the Research Team?
SAM P Most, MD
Principal Investigator
Stanford University
Are You a Good Fit for This Trial?
This trial is for adults over 18 who speak English and are having rhinoplasty either for cosmetic reasons or to treat nasal obstruction. It excludes pregnant or lactating women, those with allergies to pain meds used in the study, and anyone not undergoing nasal surgery.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Norco or Tylenol with Ibuprofen for postoperative pain management for 5 days
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Ibuprofen 200 mg
- Norco 5Mg-325Mg Tablet
- Postoperative Pain Management
- Rhinoplasty
- Tylenol 325Mg Caplet
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor